To provide early access to tipranavir and evaluate the safety and tolerance of tipranavir combined with low dose of ritonavir in patients with progressive, HIV-1 disease who have failed or are intolerant to currently approved treatments for HIV infection, who are unable to participate in another tipranavir controlled clinical trial and have an urgent need for anti-HIV treatment.
Study Type
EXPANDED_ACCESS
Tipranavir 250 mg soft elastic capsules
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
1182.58.31
Scottsdale, Arizona, United States
1182.58.29
Los Angeles, California, United States
1182.58.34 Campus Code 696446
Los Angeles, California, United States
1182.58.42 Synergy Hematology/Oncology
Los Angeles, California, United States
1182.58.43
Los Angeles, California, United States
1182.58.03
San Francisco, California, United States
1182.58.33 Kaiser Permanente Medical Center, Clinical Trials Unit
San Francisco, California, United States
1182.58.37 AIDS Health Care Foundation
Los Angeles, Connecticut, United States
1182.58.41 Circle Medical, LLC
Norwalk, Connecticut, United States
1182.58.28
Washington D.C., District of Columbia, United States
...and 136 more locations